Skip to main content
Premium Trial:

Request an Annual Quote

Becton Dickinson's Q1 Revenues Edge up Slightly

NEW YORK (GenomeWeb News) – Becton Dickinson reported today that its first-quarter 2009 revenues rose nearly 2 percent to $1.73 billion from $1.71 billion in the comparable period of 2008.

Revenues for its BD Diagnostics segment increased 3 percent to $540 million from $523 million year over year, including a negative impact of 3 percent from foreign currency translation. Its BD Biosciences segment brought in revenues of $303 million, up 11 percent from revenues of $274 million in the first quarter of 2008, and including a 1 percent benefit from currency translation. Sales for its BD Medical segment dropped 2 percent to $891 million from $909 million, including a 4 percent negative impact from currency translation.

BD's net income climbed 15 percent to $312.1 million, or $1.26 per share, from $271.5 million, or $1.07 per share, year over year.

The firm's R&D spending increased around 7 percent to $97.5 million from $91.5 million, and its SG&A expenses dropped 3 percent to $409.9 million from $421.7 million.

BD said that it expects its full-year 2009 earnings per share to increase around 9 percent to 11 percent over its EPS of $4.46 for fiscal 2008.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.